Sanara Medtech Stock Market Value
| SMTI Stock | USD 32.39 1.34 4.32% |
| Symbol | Sanara |
Sanara Medtech Price To Book Ratio
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sanara Medtech. If investors know Sanara will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sanara Medtech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.99) | Revenue Per Share | Quarterly Revenue Growth 0.352 | Return On Assets | Return On Equity |
The market value of Sanara Medtech is measured differently than its book value, which is the value of Sanara that is recorded on the company's balance sheet. Investors also form their own opinion of Sanara Medtech's value that differs from its market value or its book value, called intrinsic value, which is Sanara Medtech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sanara Medtech's market value can be influenced by many factors that don't directly affect Sanara Medtech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sanara Medtech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sanara Medtech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sanara Medtech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Sanara Medtech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Sanara Medtech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Sanara Medtech.
| 12/14/2024 |
| 03/14/2025 |
If you would invest 0.00 in Sanara Medtech on December 14, 2024 and sell it all today you would earn a total of 0.00 from holding Sanara Medtech or generate 0.0% return on investment in Sanara Medtech over 90 days. Sanara Medtech is related to or competes with InfuSystems Holdings, Pro Dex, LeMaitre Vascular, Utah Medical, Milestone Scientific, Daxor, and Meihua International. Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, a... More
Sanara Medtech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Sanara Medtech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Sanara Medtech upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 16.33 | |||
| Value At Risk | (4.59) | |||
| Potential Upside | 4.17 |
Sanara Medtech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sanara Medtech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Sanara Medtech's standard deviation. In reality, there are many statistical measures that can use Sanara Medtech historical prices to predict the future Sanara Medtech's volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | 0.0544 | |||
| Total Risk Alpha | 0.3152 | |||
| Treynor Ratio | (0.11) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Sanara Medtech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Sanara Medtech Backtested Returns
Sanara Medtech owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0104, which indicates the firm had a -0.0104 % return per unit of risk over the last 3 months. Sanara Medtech exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Sanara Medtech's Risk Adjusted Performance of (0.04), coefficient of variation of (1,832), and Variance of 8.15 to confirm the risk estimate we provide. The entity has a beta of 1.55, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Sanara Medtech will likely underperform. At this point, Sanara Medtech has a negative expected return of -0.0306%. Please make sure to validate Sanara Medtech's treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Sanara Medtech performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.69 |
Very good reverse predictability
Sanara Medtech has very good reverse predictability. Overlapping area represents the amount of predictability between Sanara Medtech time series from 14th of December 2024 to 28th of January 2025 and 28th of January 2025 to 14th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Sanara Medtech price movement. The serial correlation of -0.69 indicates that around 69.0% of current Sanara Medtech price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.69 | |
| Spearman Rank Test | -0.45 | |
| Residual Average | 0.0 | |
| Price Variance | 1.79 |
Sanara Medtech lagged returns against current returns
Autocorrelation, which is Sanara Medtech stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Sanara Medtech's stock expected returns. We can calculate the autocorrelation of Sanara Medtech returns to help us make a trade decision. For example, suppose you find that Sanara Medtech has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Sanara Medtech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Sanara Medtech stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Sanara Medtech stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Sanara Medtech stock over time.
Current vs Lagged Prices |
| Timeline |
Sanara Medtech Lagged Returns
When evaluating Sanara Medtech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Sanara Medtech stock have on its future price. Sanara Medtech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Sanara Medtech autocorrelation shows the relationship between Sanara Medtech stock current value and its past values and can show if there is a momentum factor associated with investing in Sanara Medtech.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether Sanara Medtech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sanara Medtech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sanara Medtech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sanara Medtech Stock:Check out Sanara Medtech Correlation, Sanara Medtech Volatility and Sanara Medtech Alpha and Beta module to complement your research on Sanara Medtech. For more detail on how to invest in Sanara Stock please use our How to Invest in Sanara Medtech guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Sanara Medtech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.